Marja Dubay
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
-
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
Papers in
-
- Histone Deacetylase Inhibitors Research 9
- Epigenetics and DNA Methylation 2
- Protein Degradation and Inhibitors 2
- Oncology 4
- Cancer-related Molecular Pathways 2
- Co-authors
- Robert E. Martell (11 shared papers)Claire Bonfils (6 shared papers)Zuomei Li (6 shared papers)Jeffrey M. Besterman (6 shared papers)Gregory K. Reid (2 shared papers)Ann Kalita (2 shared papers)Guillermo Garcia‐Manero (4 shared papers)Hagop M. Kantarjian (3 shared papers)
- Journals
- Blood (5 papers)Journal of Clinical Oncology (3 papers)Cancer Research (2 papers)Clinical Cancer Research (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Marja Dubay
14 papers receiving 559 citations
Peers
Comparison fields: 5 of 49
- Hematology 115
- Molecular Biology 456
- Oncology 150
- Genetics 46
- Pathology and Forensic Medicine 54
Countries citing papers authored by Marja Dubay
This map shows the geographic impact of Marja Dubay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marja Dubay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marja Dubay more than expected).
Fields of papers citing papers by Marja Dubay
This network shows the impact of papers produced by Marja Dubay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marja Dubay. The network helps show where Marja Dubay may publish in the future.
Co-authors
The 25 scholars most cited alongside Marja Dubay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 193 | |
| 2 | 2009 | 95 | |
| 3 | 2008 | 81 | |
| 4 | 2000 | 42 | |
| 5 | 1999 | 37 | |
| 6 | 2007 | 26 | |
| 7 | 2007 | 25 | |
| 8 | 2007 | 19 | |
| 9 | 2010 | 17 | |
| 10 | 2006 | 14 | |
| 11 | 2007 | 14 | |
| 12 | 2010 | 3 | |
| 13 | 2010 | 1 | |
| 14 | Induction of an anti-angiogenesis factor, Thrombospondin 1 (TSP-1), by a novel histone deacetylase inhibitor, MGCD0103, in human cancer cells in vitro and in vivo | 2008 | 1 |
About Marja Dubay
Marja Dubay is a scholar working on Molecular Biology, Oncology, Hematology, Cancer Research and Pathology and Forensic Medicine, having authored 14 papers that have together received 568 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (9 papers), Acute Myeloid Leukemia Research (4 papers), Epigenetics and DNA Methylation (2 papers), Protein Degradation and Inhibitors (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Microtubule and mitosis dynamics (2 papers), Cancer-related Molecular Pathways (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Hematology (115 citations), Molecular Biology (456 citations), Oncology (150 citations), Genetics (46 citations) and Pathology and Forensic Medicine (54 citations). Marja Dubay has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Robert E. Martell, Claire Bonfils, Zuomei Li, Jeffrey M. Besterman, Gregory K. Reid, Ann Kalita, Guillermo Garcia‐Manero, Hagop M. Kantarjian, Willie Newsome and Leonardo Brizuela. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.